Sanjay K. Gandhi, PhD

home / authors / sanjay-k-gandhi-phd

Articles

December 1st 2007

Understanding Practice Patterns and Low-density Lipoprotein Cholesterol Goal Attainment Implications of Switching Patients From Simvastatin in a Health Plan Setting

Caroline R. Harley, PhD Sanjay K. Gandhi, PhD Nze Anoka, MS, MBA Michael F. Bullano, PharmD James M. McKenney, PharmD

December 1st 2007

Comparison of Low-density Lipoprotein Cholesterol Reduction After Switching Patients on Other Statins to Rosuvastatin or Simvastatin in a Real-world Clinical Practice Setting

Kathleen M. Fox, PhD Sanjay K. Gandhi, PhD Robert L. Ohsfeldt, PhD Michael H. Davidson, MD, FACC, FACP

November 1st 2006

Effectiveness and Cost-effectiveness of Rosuvastatin, Atorvastatin, and Simvastatin Among High-Risk Patients in Usual Clinical Practice

Robert L. Ohsfeldt, PhD Sanjay K. Gandhi, PhD Kathleen M. Fox, PhD, MPH Thomas a. Stacy, PharmD James M. McKenney, PharmD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Published: November 1st 2024 | Updated: November 21st 2024

Table Multiple Myeloma Trials November 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions